Streetbeat News

Stock Prices

MCHP

Smart money investors have shown a bearish stance on Microchip Technology (NASDAQ:MCHP), with unusual options activity detected. The sentiment among these investors is split, with 36% bullish and 63% bearish. Notable options trades include both puts and calls, targeting a price range of $72.5 to $110.0 for MCHP. The company, known for its microcontrollers and analog chips, has seen a recent price increase of 0.32%, with an earnings announcement expected imminently. Analyst opinions on MCHP are mixed, with price targets ranging from $80 to $105.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 7:30 pm

DVN

Financial analysts have observed a bearish trend in options trading for Devon Energy (NYSE:DVN), with a mix of bullish and bearish sentiments among traders. The analysis highlighted unusual trades, predicting a price range for DVN between $37.5 and $52.5. Devon Energy, a major North American exploration and production company, has seen its stock price slightly increase, with professional analysts maintaining optimistic target prices despite the bearish options sentiment.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 7:30 pm

ROP

Over the past 10 years, Roper Techs (NASDAQ:ROP) has produced an average annual return of 15.19%, outperforming the market by 4.42%. A $100 investment in ROP a decade ago would now be worth $411.21. Roper Techs currently has a market capitalization of $57.36 billion.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 7:30 pm

CDW

Over the past 10 years, CDW (NASDAQ:CDW) has significantly outperformed the market, with an annualized return of 25.66%. A $1000 investment in CDW a decade ago would now be worth $9,788.19. This showcases the impact of compounded returns on investment growth over time. CDW's current market capitalization stands at $30.45 billion.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 7:30 pm

DWAC

RUM

Digital World Acquisition Corporation (DWAC) is testing a video streaming platform for Truth Social, potentially impacting its partnership with Rumble Inc (RUM). DWAC's merger with Trump Media & Technology Group (TMTG) includes plans to expand Truth Social's offerings, potentially competing with Rumble, which currently hosts Trump's videos. This development could affect Rumble's stock, which has seen volatility linked to Trump's political activities.

Portfolio Pulse from Chris Katje

February 01, 2024 | 7:27 pm

OKTA

ZM

Zoom Video Communications, Inc. (NASDAQ:ZM) is reducing its workforce by approximately 150 jobs, less than 2% of its total employees, focusing on realigning its team with strategic goals, particularly in AI, sales, and engineering for 2024 growth. Separately, Okta, Inc. (NASDAQ:OKTA) announced a 7% workforce reduction as part of cost-cutting measures. ZM's stock saw a slight increase of 0.03% to $64.63.

Portfolio Pulse from Nabaparna Bhattacharya

February 01, 2024 | 7:21 pm

CMPR

HON

NRBO

PTON

U.S. stocks traded higher with the Dow Jones gaining around 250 points. Honeywell International Inc reported downbeat Q4 revenue and a weak outlook, missing consensus estimates. Cimpress plc, NeuroBo Pharmaceuticals, and Celularity Inc saw significant stock price increases following positive financial results and clinical trial news. Conversely, Revelation Biosciences, Peloton Interactive, and Volcon Inc experienced substantial declines in their stock prices due to disappointing financial results and public offering pricing.

Portfolio Pulse from Avi Kapoor

February 01, 2024 | 7:20 pm

GSK

GSK Plc (NYSE:GSK) resolved a U.S. lawsuit related to its heartburn medicine Zantac, avoiding a trial in California. The settlement with plaintiff David Browne was confidential, with no admission of liability by GSK. This follows a similar settlement in October and the resolution of three breast cancer bellwether cases in California. GSK's recent performance and vaccine launches have been positive, despite past issues with Zantac, which was pulled from the market in 2020 due to carcinogenic concerns. GSK shares rose 2.94% to $40.60.

Portfolio Pulse from Vandana Singh

February 01, 2024 | 7:19 pm

GOOS

Canada Goose shares surged following the announcement of their Q3 financial results and future guidance. The positive financial performance and optimistic outlook have contributed to the stock's upward movement.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 7:17 pm

ORCL

Oracle (NYSE:ORCL) has seen significant options activity, with a bearish sentiment prevailing among investors. Analysis of 21 trades shows 71% bearish and 28% bullish expectations. Notable trades include bearish puts and calls with strike prices ranging from $70 to $140. Current trading volume and price movements suggest a potential overbought condition, with ORCL's price recently up 1.21% to $113.05.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 7:15 pm